Abstract
Dipivefrin (Propine) is an effective ocular hypotensive agent. Follicular conjunctivitis has been observed in an unexpectedly high incidence of glaucoma patients on this topical therapy. Severe discomfort was experienced by a few patients. Follicles resolved after withdrawal of this medication, but may persist or recur upon subsequent treatment with other adrenaline related compounds. Regular examination of the conjunctiva is recommended for early signs of this side-effect, which initially may be symptom free.
Similar content being viewed by others
Article PDF
References
McGuinness R and Frumar KD : Timolol and dipvalyl epinephrine. Aust J Ophthalmol 1982, 10: 179–82.
Fraunfelder FT : Drug-induced ocular side-effects and drug interactions. 2nd Edition Lea and Ferbiger(Philadelphia) 1982.
Wilson FM : Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol 1979, 24: 57–88.
Liesegang TJ : Bulbar conjunctival follicles associated with Dipivefrin therapy. Ophthalmology 1985, 92:228–33.
Theodore J and Leibowitz HM : External ocular. Ophthalmol 1979, 88:1013–6.
Wandel T and Spinak M : Ophthalmology 1981, 88:259–60.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coleiro, J., Sigurdsson, H. & Lockyer, J. Follicular conjunctivitis on dipivefrin therapy for glaucoma. Eye 2, 440–442 (1988). https://doi.org/10.1038/eye.1988.80
Issue Date:
DOI: https://doi.org/10.1038/eye.1988.80